BRIEF published on 07/16/2026 at 09:12, 22 days 15 hours ago Valerio Therapeutics and Abivax join forces for innovative therapies Abivax Collaboration Inflammatory Diseases Valerio Therapeutics RNA Therapies
BRIEF published on 07/16/2026 at 09:12, 22 days 15 hours ago Valerio Therapeutics Partners with Abivax for RNA Therapeutics Development Biotechnology Valerio Therapeutics Pipelines RNA Therapeutics Abivax Collaboration
PRESS RELEASE published on 07/16/2026 at 09:07, 22 days 15 hours ago Inside Information / Other news releases Valerio Therapeutics partners with Abivax for global collaboration, providing pipeline update on RNA therapeutics. Initial payment up to €2.4 million Abivax Collaboration Valerio Therapeutics Pipeline Update RNA Therapeutics
BRIEF published on 07/01/2026 at 09:27, 1 month 6 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
BRIEF published on 07/01/2026 at 09:27, 1 month 6 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
PRESS RELEASE published on 07/01/2026 at 09:22, 1 month 6 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
BRIEF published on 06/16/2026 at 19:48, 1 month 21 days ago Valerio Therapeutics Appoints New CEO and Confirms AGM Resolutions Biotechnology CEO Transition Valerio Therapeutics Gilles Besin RNA Medicines
PRESS RELEASE published on 06/16/2026 at 19:43, 1 month 21 days ago Inside Information / Other news releases Valerio Therapeutics appoints Gilles Besin as CEO, approved all resolutions at annual general meeting. Besin brings deep RNA and targeted delivery expertise to drive innovation Annual General Meeting Valerio Therapeutics Gilles Besin RNA Medicines Targeted Delivery
BRIEF published on 12/17/2025 at 11:02, 7 months 21 days ago Valerio Therapeutics Welcomes Professor Eric Vivier to its Board of Directors Board Of Directors Oncology Immunology Valerio Therapeutics Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 7 months 21 days ago Valerio Therapeutics Appoints Professor Eric Vivier as Board Observer Board Of Directors Immunology Valerio Therapeutics Professor Eric Vivier Oncology Strategy
Published on 08/07/2026 at 23:15, 1 hour 39 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 hour 54 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 hours 24 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 hours 39 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 1 hour 33 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 5 hours 24 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 5 hours 39 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 6 hours 44 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 17:45, 7 hours 9 minutes ago Schroder ETFs ICAV: Publication of the Audited Annual Report for Switzerland
Published on 08/07/2026 at 18:54, 6 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 6 hours 14 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 7 hours 5 minutes ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 16 hours 24 minutes ago Disclosure of shares outstanding and voting rights - 07.08.2026
